This firm is undervalued at 5.02 per share with modest projections ahead.
On a scale of 0 to 100, InflaRx NV holds a
performance score of 7. The company retains a Market Volatility (i.e., Beta) of 0.5251, which attests to possible diversification benefits within a given portfolio. Let's try to break down what InflaRx's beta means in this case. As returns on the market increase, InflaRx NV returns are expected to increase less than the market. However, during the bear market, the loss on holding InflaRx NV will be expected to be smaller as well. Although it is vital to follow
InflaRx NV current price history, it is good to be conservative about what you can do with the information regarding equity current price movements. The philosophy towards determining
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. We have found twenty-eight
technical indicators for InflaRx NV, which you can use to evaluate the performance of the firm. Please utilizes InflaRx NV
total risk alpha, as well as the
relationship between the downside variance and
daily balance of power to make a quick decision on whether InflaRx NV current trending patterns will revert.
The performance of InflaRx NV in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence InflaRx NV's
stock prices. When investing in InflaRx NV, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, InflaRx Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as InflaRx NV carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.
How important is InflaRx NV's Liquidity
InflaRx NV
financial leverage refers to using borrowed capital as a funding source to finance InflaRx NV ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. InflaRx NV financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to InflaRx NV's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of InflaRx NV's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between InflaRx NV's total debt and its cash.
What do experts say about InflaRx?
Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
Analysis ConsensusA Deeper Perspective
InflaRx NV secures a total of 44.2 Million outstanding shares. InflaRx NV retains 14.9 (percent) if its
outstanding shares held by
insiders and 14.9 (percent) owned by
outside corporations . Remember, it does not matter who owns the company or if the company is currently
losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Ownership Breakdown
| Retail Investors75.66% | Insiders14.9% | Institutions9.44% |
| Retail Investors | 75.66 |
| Insiders | 14.9 |
| Institutions | 9.44 |
Will InflaRx NV continue to go out of control?
Current information ratio is at 0.11.
As of the 27th of December, InflaRx NV retains the Downside Deviation of 4.21,
market risk adjusted performance of 1.4, and Risk Adjusted Performance of 0.186. InflaRx NV
technical analysis makes it possible for you to employ
historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen
technical drivers for InflaRx NV, which can be compared to its competitors. Please check out
InflaRx NV mean deviation,
information ratio, as well as the
relationship between the Information Ratio and
downside variance to decide if InflaRx NV is priced fairly, providing market reflects its last-minute price of 3.08 per share. Given that InflaRx NV has
jensen alpha of 0.6523, we strongly advise you to confirm InflaRx NV's regular market performance to make sure the company can sustain itself at a future point.
Our Final Takeaway
While some firms in the biotechnology industry are either recovering or due for a correction, InflaRx NV may not be performing as strong as the other in terms of long-term growth potentials. To conclude, as of the 27th of December 2022, we believe InflaRx NV is currently
undervalued. It follows the market closely and projects
very small probability of distress in the next two years. Our present 90 days recommendation on the company is
Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Aina Ster is a Member of Macroaxis Editorial Board. Aina delivers weekly perspective on ongoing market and economic trends, analysis and tips from predictive analysis to forecasting across various financial instruments.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of InflaRx NV. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]